表紙
市場調查報告書

全球受託研究機構(CRO)市場預測(2020∼2030):各類服務,各用途,各終端用戶預測與分析,主要各地區、國家預測,市場參與企業簡介

Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030: Forecasts & Analysis by Service, by Application, by End-User, including Forecasts by Major Regions and Countries, plus Profiles of Leading Companies in the Market

出版商 Visiongain Ltd 商品編碼 933200
出版日期 內容資訊 英文 215 Pages
商品交期: 最快1-2個工作天內
價格
全球受託研究機構(CRO)市場預測(2020∼2030):各類服務,各用途,各終端用戶預測與分析,主要各地區、國家預測,市場參與企業簡介 Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030: Forecasts & Analysis by Service, by Application, by End-User, including Forecasts by Major Regions and Countries, plus Profiles of Leading Companies in the Market
出版日期: 2020年02月12日內容資訊: 英文 215 Pages
簡介

全球受託研究機構(CRO)市場在過去數年,將以年複合成長率9.5%左右擴大。2020年預計380億美元,不過,預計至2030年成為940億美元的規模。專利的失效,學名藥的普及等,擴大業務對CRO的外包。還有製藥公司臨床實驗成本的削減和效率化的需求,成為促進對CRO的外包的要素。

本報告提供全球受託研究機構(CRO)市場相關調查,市場概要和各市場區隔趨勢,各地區趨勢,及參與企業的簡介相關資訊彙整。

第1章 報告概要

第2章 全球CRO市場

  • 市場規模與預測
  • 各類服務市場
  • 各用途市場
  • 各終端用戶市場
  • 各地區市場

第3章 臨床實驗流程與CRO功能服務:概要

  • 簡介
  • 臨床實驗流程和階段
  • 第一階段
  • 第二階段
  • 第三階段
  • 上市後監測和第四階段
  • 法律制度

第4章 全球CRO市場趨勢

  • 臨床實驗的複雜化
  • 中小規模的生物製藥的創新
  • 生物相似藥
  • 適應臨床實驗設計
  • 風險為基礎的監測
  • 現實的證據
  • 對現有藥物的新適應的再利用
  • 學名藥市場復興造成的競爭激烈化
  • SWOT分析

第5章 北美

第6章 歐洲

第7章 亞太地區

第8章 其他各國

第9章 競爭環境

第10章 企業簡介

  • CHARLES RIVER LABORATORIES
  • FRONTAGE LABORATORIES, INC.,
  • ICON PLC
  • SYNEOS HEALTH, INC.
  • LABCORP/COVANCE
  • PAREXEL
  • PHARMACEUTICAL PRODUCT DEVELOPMENT
  • PRA HEALTH SERVICES
  • QUINTILES
  • WUXIAPPTEC

第11章 結論

第12章 附錄

目錄
Product Code: PHA0672

The new report from business intelligence provider Visiongain offers an updated outlook for the global clinical research organizations (CROs) market. Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020. Contract research organizations (CROs) have become essential to pharmaceutical, biotech and other medical-related industries by supporting their clients' efforts to test, refine and market the latest pharmaceuticals and medical devices through clinical trials.

The global CRO market value has grown by nearly a 9.5% compound annual growth rate (CAGR) over the past several years and is expected to reach $38 billion in 2020 and $94 billion by 2030, as specialized demand, patent expiration and proliferation of generic medications are all leading to greater outsourcing of work to CROs. Also driving the trend toward CRO outsourcing is pharmaceutical companies' (pharma companies') increasing need to reduce clinical trial costs and improve efficiencies. This in turn is increasing time-to-market urgencies for pharma companies while also leading to pricing pressures and greater margin awareness. Pharmaceutical companies are focusing on niche sector CROs to expand their knowledgebase in highly complex trial areas, and functional service provider (FSP) contracts are allowing them the ability to outsource individual services rather than entire studies or projects. This integrated Pharma-CRO partnership leads to efficiency gains and is often desirable for studies of high complexity, tight time constraints and/or broader scope.

Strong demand and increased competitiveness are facilitating mergers and partnerships to enhance larger companies' full-service capabilities and international reach. Recovery of capital markets and strong revenue potential are boosting CRO valuations, which is also increasing merger and acquisition (M&A) activity and public offerings in the industry.

CROs are benefiting from top-line growth among deep-pocketed pharmaceutical companies in addition to several drivers specific to current industry trends. Pharmaceutical companies are bringing a record number of drugs to market in a more time-sensitive and competitive environment. As acceleration of time-to-market and increased cost-effectiveness have become critical, CROs are capitalizing on their expertise in specific areas of the clinical research process.

Pharma pipelines are currently ripe with new-age, complex therapies that are nearing market readiness. Regenerative cell-based therapies, chimeric antigen receptor (CAR)-modified T cell therapy (CAR-T), immune-oncology combinations and innovative autoimmune therapies are just some of the new fields being studied in clinical trials across the globe. More adept use of data and analytics by pharma and CROs is leading to more appropriate patient trial selection and more adaptive trial designs. Adaptive design studies, risk-based monitoring and other flexible approaches can reduce costs while allowing adaptions as studies progress. These trends mitigate risks for pharma companies and patient pools while facilitating the pursuit of more potential therapies and enhancing the drug discovery pipeline. Correspondingly, patient receptiveness is at an all-time high. These factors are all contributing to the rapid proliferation of clinical trials in the U.S. and throughout the globe.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in the clinical research organizations (CROs) sector. Visiongain's new study tells you and tells you NOW.

In this brand-new report, you will receive 214 in-depth tables, charts and graphs - all unavailable elsewhere.

The 215-page report provides clear detailed insight into the global clinical research organizations (CROs) market. It reveals the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you will be better informed and ready to act.

Report Scope

Global clinical research organizations (CROs) market forecasts from 2020-2030

Regional clinical research organizations (CROs) market forecasts from 2020-2030 covering

  • North America
  • South America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Middle East and Africa

Country level clinical research organizations (CROs) forecasts from 2020-2030 covering

  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • Japan
  • Brazil
  • India
  • RoW

Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering services

  • Drug Discovery
  • Pre-Clinical & Clinical
  • Laboratory Services
  • Other Service

Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering Application

  • Cardiology
  • Infectious Disease
  • Oncology
  • Metabolic Disorders
  • Other Applications

Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering End-Users

  • Pharmaceutical & Biotechnological Companies
  • Academic & Research Institutes
  • Analysis of the key factors driving growth in the global, regional and country level clinical research organizations (CROs) markets from 2020-2030

Profiles and competitive positioning map of the leading 10 clinical research organizations (CROs) companies:

  • Charles River Laboratories
  • Frontage Laboratories, Inc.,
  • Icon Plc
  • Syneos Health, Inc. (Inc Research/Inventive Health)
  • LabCorp/Covance
  • Parexel
  • Pharmaceutical Product Development
  • PRA Health Services
  • Quintiles
  • WuXiAppTec

How will you benefit from this report?

  • This report will keep your clinical research organizations (CROs) knowledge base up to speed. Don't get left behind
  • This report will reinforce strategic decision decision-making based upon definitive and reliable market data
  • You will learn how to exploit new clinical research organizations (CROs) technological trends
  • You will be able to realise your company's full potential within the market
  • You will better understand the competitive landscape and identify potential new business opportunities & partnerships

Who should read this report?

  • Anyone within the pharma & value chain
  • Investment analysts
  • Investment consultancies
  • CEO's
  • COO's
  • CIO's
  • Business development managers
  • Marketing managers

Visiongain's study is intended for anyone requiring commercial analyses for the clinical research organizations (CROs) market and leading companies. You will find data, trends and predictions.

Buy our report today Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030: Forecasts & Analysis by Service, by Application, by End-User Including Forecasts by Major Regions and Countries, Plus Profiles of Leading Companies in the Market. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

TABLE OF CONTENTS

1. REPORT OVERVIEW

  • 1.1 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET OVERVIEW
    • 1.1.1 Pharma-CRO Relationships
  • 1.2 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET SEGMENTATION
  • 1.3 MARKET DEFINITION
  • 1.4 HOW THIS REPORT DELIVERS
  • 1.5 KEY QUESTIONS ANSWERED BY THIS ANALYTICAL REPORT INCLUDE:
  • 1.6 WHY YOU SHOULD READ THIS REPORT?
  • 1.7 WHO IS THIS REPORT FOR?
  • 1.8 METHODOLOGY
  • 1.9 FREQUENTLY ASKED QUESTIONS (FAQ)
  • 1.10 ASSOCIATED VISIONGAIN REPORTS
  • 1.11 ABOUT VISIONGAIN

2. GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CRO) MARKET

  • 2.1. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE AND FORECAST (2020-2030)
  • 2.2. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY SERVICE
  • 2.3. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY APPLICATION
    • 2.3.1 Oncology
    • 2.3.2 Infectious Diseases
    • 2.3.3 Metabolic Disorders
    • 2.3.4 Cardiology
  • 2.4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY END-USER
    • 2.4.1 PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES
    • 2.4.2 ACADEMIC RESEARCH ORGANIZATION (ARO)
  • 2.5. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY REGION

3. CLINICAL TRIAL PROCESS AND CRO FUNCTIONAL SERVICES- AN OVERVIEW

  • 3.1 INTRODUCTION
  • 3.2 CLINICAL TRIAL PROCESS AND STAGES
    • 3.2.1 Pre-discovery
    • 3.2.2 Drug Discovery
    • 3.2.3 Preclinical
    • 3.2.4 Clinical
  • 3.3 PHASE I
  • 3.4 PHASE II
  • 3.5 PHASE III
  • 3.6 POST-MARKETING SURVEILLANCE AND PHASE IV STUDIES
  • 3.7 REGULATORY ENVIRONMENT
    • 3.7.1 FDA REGULATION AND IMPACT
    • 3.7.2 The Declaration of Helsinki
    • 3.7.3 CDISC Standards

4. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET TRENDS

  • 4.1 INCREASING COMPLEXITY OF CLINICAL TRIALS
  • 4.2 SMALL AND MID-SIZED BIOPHARMA INNOVATION
    • 4.2.1 Small Molecule Versus Biologics
  • 4.3 BIOSIMILARS
  • 4.4 ADAPTIVE TRIAL DESIGN
  • 4.5 RISK-BASED MONITORING
  • 4.6 REAL WORLD EVIDENCE
  • 4.7 REPURPOSING EXISTING DRUGS FOR NEW INDICATIONS
  • 4.8 INCREASED COMPETITION THROUGH THE RESURGENCE OF THE GENERIC DRUG MARKET
  • 4.9 SWOT ANALYSIS OF GLOBAL CLINICAL RESEARCH ORGANIZATIONS

5. NORTH AMERICA MARKET FOR CONTRACT RESEARCH ORGANIZATION

  • 5.1 NORTH AMERICA CRO MARKET BY SERVICE
  • 5.2 NORTH AMERICA CRO MARKET BY APPLICATION
  • 5.3 NORTH AMERICA CRO MARKET BY END USERS
  • 5.4 NORTH AMERICA CRO MARKET BY, COUNTRY
    • 5.4.1 United States of America
    • 5.4.2 Canada
    • 5.4.3 Mexico

6. EUROPE MARKET FOR CONTRACT RESEARCH ORGANISATION

  • 6.1 EUROPE CRO MARKET BY SERVICE
  • 6.2 EUROPE CRO MARKET BY APPLICATIONS
  • 6.3 EUROPE CRO BY END USERS
  • 6.4 EUROPE CRO BY COUNTRY
    • 6.4.1 Germany
    • 6.4.2 United Kingdom
    • 6.4.3 France
    • 6.4.4 Spain
    • 6.4.5 Italy

7. ASIA-PACIFIC MARKET FOR CONTRACT RESEARCH ORGANISATION

  • 7.1 ASIA-PACIFIC CRO MARKET BY SERVICE
  • 7.2 ASIA-PACIFIC CRO BY APPLICATION
  • 7.3 ASIA-PACIFIC CRO BY END USER
  • 7.4 ASIA-PACIFIC CRO MARKET BY COUNTRY
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 Australia

8. REST OF WORLD MARKET FOR CONTRACT RESEARCH ORGANISATION

  • 8.1 REST OF WORLD CRO BY SERVICE
  • 8.2 REST OF WORLD CRO BY APPLICATIONS
  • 8.3 REST OF WORLD CRO BY END USERS
  • 8.4 REST OF WORLD CRO BY COUNTRY
    • 8.4.1 South Africa
    • 8.4.2 Brazil

9. COMPETITIVE LANDSCAPE

  • 9.1FUNCTIONAL SERVICE PROVIDER RELATIONSHIPS
  • 9.2 OFF SHORING
  • 9.3THERAPEUTIC AREAS IN DRUG DEVELOPMENT
  • 9.4 CURRENT PHARMA-CRO CONTRACTS
  • 9.5 LARGEST THERAPEUTIC AREAS RELY ON KEY CRO EXPERTISE
  • 9.6 MERGERS AND ACQUISITIONS
    • 9.6.1 Recent Merger and Acquisition Activity
      • 9.6.1.1 Charles River Laboratories

10 COMPANY PROFILES

  • 10.1 CHARLES RIVER LABORATORIES
    • 10.1.1 Company Overview
    • 10.1.2 Company Financials
    • 10.1.3 Company Recent Developments
  • 10.2 FRONTAGE LABORATORIES, INC.,
    • 10.2.1 Company Overview
    • 10.2.2 Company Financials
    • 10.2.3 Company Recent Developments
  • 10.3 ICON PLC
    • 10.3.1 Company Overview
    • 10.3.2 Company Products & Services
    • 10.3.3 Company Financials
    • 10.3.4 Company Recent Developments
  • 10.4 SYNEOS HEALTH, INC. (INC RESEARCH/INVENTIVE HEALTH)
    • 10.4.1 Company Overview
    • 10.4.2 Company Financials
    • 10.4.3 Company Recent Developments
  • 10.5 LABCORP/COVANCE
    • 10.5.1 Company Overview
    • 10.5.2 Company Financials
    • 10.5.3 Company Recent Developments
  • 10.6PAREXEL
    • 10.6.1 Company Overview
    • 10.6.2 Company Products & Services
    • 10.6.3 Company Financials
  • 10.7 PHARMACEUTICAL PRODUCT DEVELOPMENT
    • 10.7.1 Company Overview
    • 10.7.2 Company Products & Services
    • 10.7.3 Company Recent Developments
  • 10.8 PRA HEALTH SERVICES
    • 10.8.1 Company Overview
    • 10.8.2 Company Products & Services
    • 10.8.3 Company Financials
    • 10.8.4 Company Recent Developments
  • 10.9 QUINTILES
    • 10.9.1 Company Overview
    • 10.9.2 Company Financials
    • 10.9.3 Company Recent Developments
  • 10.10 WUXIAPPTEC
    • 10.10.1 Company Overview
    • 10.10.2 Company Products & Services
    • 10.10.3 Company Financials
    • 10.10.4 Company Recent Developments

11.CONCLUSION

12. GLOSSARY

  • 12.1 TECHNICAL DEFINITIONS
    • ASSOCIATED VISIONGAIN REPORTS
    • VISIONGAIN REPORT SALES ORDER FORM
    • APPENDIX A
    • ABOUT VISIONGAIN
    • APPENDIX B
    • VISIONGAIN REPORT EVALUATION FORM

List of Tables

  • Table 2.1 Global Contract Research Organizations Market, 2020-2030 (US$ Billion)
  • Table 2.2 Global Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Table 2.3 Global Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Table 2.4 Global Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Table 2.5 Global Contract Research Organizations Market by Region, 2020-2030 (US$ Billion)
  • Table 3.1 Likelihood of Approval, by Major Disease Area/Phase (%)
  • Table 3.2 Clinical Phase Description
  • Table 3.3 New Drug Approvals: New Drugs Entering the Market at an Increasing Pace Until Last Year, 2006-2018
  • Table 5.1 North America Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Table 5.2 North America Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Table 5.3 North America Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Table 5.4 North America Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)
  • Table 5.5 List of Contract Research Organizations in U.S.
  • Table 5.6 List of Contract Research Organizations in Canada
  • Table 5.7 List of Contract Research Organizations in Mexico
  • Table 6.1 Europe Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Table 6.2 Europe Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Table 6.3 Europe Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Table 6.4 Europe Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)
  • Table 6.5 List of Contract Research Organizations in Germany
  • Table 6.6 List of Contract Research Organizations in the U.K.
  • Table 6.7 List of Contract Research Organizations in France
  • Table 6.8 List of Contract Research Organizations in Spain
  • Table 6.9 List of Contract Research Organizations in Italy
  • Table 7.1 Asia-Pacific Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Table 7.2 Asia-Pacific Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Table 7.3 Asia-Pacific Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Table 7.4 Asia-Pacific Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)
  • Table 7.5 List of Contract Research Organizations in China
  • Table 7.6 List of Contract Research Organizations in India
  • Table 7.7 List of Contract Research Organizations in Japan
  • Table 7.8 List of Contract Research Organizations in Australia
  • Table 7.9 RoW Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Table 7.10 RoW Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Table 8.1 RoW Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Table 8.2 RoW Contract Research Organizations Market by Country, 2020-2030 (US$ Billion)
  • Table 8.3 List of Contract Research Organizations in South Africa
  • Table 8.4 List of Contract Research Organizations in Brazil
  • Table 9.1 Comparative View of Services Provided by CRO Companies
  • Table 9.2 Key Players in Therapeutic Areas
  • Table 9.3 Strategic alliances, CROs and pharma/CRO alliances are shaping future landscape.
  • Table 9.4 M &A Activity Among Pharma/CROs: Recent M &A Deals in Pharma Outsourcing Sector ($ Millions)
  • Table 9.5 Deal Types in CRO Sector: Improving Capital Markets Leading to More IPOs ($ Millions)
  • Table 10.1 Charles River Laboratories Company Details
  • Table 10.2 Charles River Laboratories Product and Service Offerings
  • Table 10.3 Charles River Laboratories Recent Developments
  • Table 10.4 Frontage Laboratories, Inc., Company Details
  • Table 10.5 Frontage Laboratories, Inc., Services
  • Table 10.6 Frontage Laboratories, Inc., Company Recent Developments
  • Table 10.7 Icon Plc Company Details
  • Table 10.8 ICON Product and Service Offerings
  • Table 10.9 ICON Company Recent Developments
  • Table 10.10 Syneos Health, Inc. Company Details
  • Table 10.11 Syneos Health, Inc. Company Recent Developments
  • Table 10.12 LabCorp/Covance Company Details
  • Table 10.13 LabCorp/Covance Company Recent Developments
  • Table 10.14 Parexel Company Details
  • Table 10.15 Parexel Product and Service Offerings
  • Table 10.16 Pharmaceutical Product Development Company Details
  • Table 10.17 Pharmaceutical Product Development Product and Service Offerings
  • Table 10.18 Pharmaceutical Product Development Company Recent Developments
  • Table 10.19 PRA Health Services Company Details
  • Table 10.20 PRA Health Services Product and Service Offerings
  • Table 10.21 PRA Health Services Company Recent Developments
  • Table 10.22 Quintiles Company Details
  • Table 10.23 Quintiles Product and Service Offerings
  • Table 10.24 WuXiAppTec Company Details
  • Table 10.25 WuXiAppTec Product and Service Offerings
  • Table 10.26 WuXiAppTec Company Recent Developments

List of Figures

  • Figure 1.1 Total Number of Registered Clinical Studies Worldwide, 2000-2019
  • Figure 1.2 Global Contract Research Organizations (CRO) Market Segmentation
  • Figure 2.1 Global Contract Research Organizations Market, 2020-2030 (US$ Billion)
  • Figure 2.2 Global Contract Research Organizations Market by Service, 2020-2030 (US$ Billion)
  • Figure 2.3 Global Contract Research Organizations Market by End-Use, 2020-2030 (US$ Billion)
  • Figure 2.4 Global Contract Research Organizations Market by Application, 2020-2030 (US$ Billion)
  • Figure 2.5 Global Contract Research Organizations Market by Region, 2020-2030 (US$ Billion)
  • Figure 3.1 Stages of Clinical Developments
  • Figure 3.2 Drug Approval Timeline
  • Figure 4.1 Total Number of Trial Registrations by WHO, Region, 1999-2018
  • Figure 5.1 Contract Research Organization Map in U.S. ( 8887 Labs)
  • Figure 5.2 Contract Research Organization Map in Canada (663 Labs)
  • Figure 5.3 Contract Research Organization Map in Mexico (29 Labs)
  • Figure 6.1 Contract Research Organization Map in Germany ( 1050 Labs)
  • Figure 6.2 Contract Research Organization Map in the U.K. ( 1378 Labs)
  • Figure 6.3 Contract Research Organization Map in France ( 534 Labs)
  • Figure 6.4 Contract Research Organization Map in Spain (237 Labs)
  • Figure 6.5 Contract Research Organization Map in Italy (284 Labs)
  • Figure 7.1 Contract Research Organization Map in China (653 Labs)
  • Figure 7.2 Contract Research Organization Map in India (589 Labs)
  • Figure 7.3 Contract Research Organization Map in Japan (279 Labs)
  • Figure 7.4 Contract Research Organization Map in Australia (254 Labs)
  • Figure 8.1 Contract Research Organization Map in South Africa ( 53 Labs)
  • Figure 8.2 Contract Research Organization Map in Brazil (45 Labs)
  • Figure 9.1 Global CRO Competitor Market Share, by Company, 2019
  • Figure 9.2 Leading CROs' Preclinical CRO Market Share, by Company, 2019
  • Figure 10.1 Charles River Laboratories Total Revenue 2016-2018
  • Figure 10.2 Charles River Laboratories EBITA 2016-2018
  • Figure 10.3 Charles River Laboratories Net Income 2016-2018
  • Figure 10.4 Frontage Laboratories, Inc. Total Revenue 2016-2018
  • Figure 10.5 Frontage Laboratories, Inc. EBITA 2016-2018
  • Figure 10.6 Frontage Laboratories, Inc. Net Income 2016-2018
  • Figure 10.7 ICON Company Total Revenue 2016-2018
  • Figure 10.8 ICON Company Total EBITA 2016-2018
  • Figure 10.9 ICON Company Net Income 2016-2018
  • Figure 10.10 Syneos Health, Inc. Total Revenue 2016-2018
  • Figure 10.11 Syneos Health, Inc. EBITA 2016-2018
  • Figure 10.12 Syneos Health, Inc. Net Income 2016-2018
  • Figure 10.13 LabCorp/Covance Company Total Revenue 2016-2018
  • Figure 10.14 LabCorp/Covance Company EBITA 2016-2018
  • Figure 10.15 LabCorp/Covance Company Net Income 2016-2018
  • Figure 10.16 Parexel Company Total Revenue 2016-2018
  • Figure 10.17 Parexel Company EBITA 2016-2018
  • Figure 10.18 Parexel Company Net Income 2016-2018
  • Figure 10.19 PRA Health Services Company Total Revenue 2016-2018
  • Figure 10.20 PRA Health Services Company EBITA 2016-2018
  • Figure 10.21 PRA Health Services Company Net Income 2016-2018
  • Figure 10.22 Quintiles Company Total Revenue 2016-2018
  • Figure 10.23 Quintiles Company EBITA 2016-2018
  • Figure 10.24 Quintiles Company Net Income 2016-2018
  • Figure 10.25 Quintiles Company Recent Developments
  • Figure 10.26 WuXiAppTec Total Revenue 2016-2018
  • Figure 10.27 WuXiAppTec EBITA 2016-2018
  • Figure 10.28 WuXiAppTec Net Income 2016-2018